Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 11;14(3):579.
doi: 10.3390/v14030579.

Therapeutic Strategies against Ebola Virus Infection

Ching-Hsuan Liu  1 , Yee-Tung Hu  2 , Shu Hui Wong  3 , Liang-Tzung Lin  1   2
Affiliations
Review

Therapeutic Strategies against Ebola Virus Infection

Ching-Hsuan Liu et al. Viruses. .

Abstract

Since the 2014-2016 epidemic, Ebola virus (EBOV) has spread to several countries and has become a major threat to global health. EBOV is a risk group 4 pathogen, which imposes significant obstacles for the development of countermeasures against the virus. Efforts have been made to develop anti-EBOV immunization and therapeutics, with three vaccines and two antibody-based therapeutics approved in recent years. Nonetheless, the high fatality of Ebola virus disease highlights the need to continuously develop antiviral strategies for the future management of EBOV outbreaks in conjunction with vaccination programs. This review aims to highlight potential EBOV therapeutics and their target(s) of inhibition, serving as a summary of the literature to inform readers of the novel candidates available in the continued search for EBOV antivirals.

Keywords: Ebola virus; Ebola virus disease; antiviral; drug development; therapeutic.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Kuhn J.H., Amarasinghe G.K., Perry D.L. Filoviridae. In: Howley P.M., Knipe D.M., Whelan S., editors. Fields Virology. 7th ed. Volume 1. Wolters Kluwer; Philadelphia, PA, USA: 2021. pp. 449–503.
    1. Kuhn J.H., Amarasinghe G.K., Basler C.F., Bavari S., Bukreyev A., Chandran K., Crozier I., Dolnik O., Dye J.M., Formenty P.B.H., et al. ICTV Virus Taxonomy Profile: Filoviridae. J. Gen. Virol. 2019;100:911–912. doi: 10.1099/jgv.0.001252. - DOI - PMC - PubMed
    1. Jacob S.T., Crozier I., Fischer W.A., Hewlett A., Kraft C.S., Vega M.-A.d.L., Soka M.J., Wahl V., Griffiths A., Bollinger L., et al. Ebola virus disease. Nat. Rev. Dis. Primers. 2020;6:13. doi: 10.1038/s41572-020-0147-3. - DOI - PMC - PubMed
    1. Dudas G., Carvalho L.M., Bedford T., Tatem A.J., Baele G., Faria N.R., Park D.J., Ladner J.T., Arias A., Asogun D. Virus genomes reveal factors that spread and sustained the Ebola epidemic. Nature. 2017;544:309–315. doi: 10.1038/nature22040. - DOI - PMC - PubMed
    1. Dietzel E., Schudt G., Krähling V., Matrosovich M., Becker S. Functional characterization of adaptive mutations during the West African Ebola virus outbreak. J. Virol. 2017;91:e01913-16. doi: 10.1128/JVI.01913-16. - DOI - PMC - PubMed

Publication types